On August 3, 2021 Tango Therapeutics Inc., a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, reported that Barbara Weber, MD, President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a panel on synthetic lethality in cancer therapeutics at the 12th Annual Wedbush PacGrow Healthcare Conference on Tuesday, August 10 at 11:30 AM ET (Press release, Tango Therapeutics, AUG 3, 2021, View Source [SID1234585638]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the event will be available under the "Events & Presentations" tab on the "Investors" page on the Company’s website on the day of the event. A replay of the webcast will be archived on the Company’s website for 30 days following the presentation.